Literature DB >> 32173199

Inhibitory effects of biseokeaniamide A against lipopolysaccharide-induced signal transduction.

Osamu Ohno1, Takuro Terasaki2, Takuya Sano2, Yuki Hitomi2, Junichiro Miyamoto2, Kenji Matsuno3.   

Abstract

Lipopolysaccharides (LPS) are associated with various inflammatory diseases; therefore, the inhibition of LPS-induced nitric oxide (NO) production may have extensive therapeutic applications. We searched for inhibitors of NO production in the LPS-stimulated murine macrophage-like cell line RAW264.7 from MeOH extracts of marine organisms. The MeOH extract of the marine cyanobacterium Okeania sp., collected in Okinawa, Japan, showed inhibitory activity. Biseokeaniamide A was isolated from the MeOH extract by chromatographic separation. Biseokeaniamide A inhibited NO production without cytotoxicity. It reduced inducible nitric oxide synthase levels and suppressed the expression of IL-1β in LPS-stimulated RAW264.7 cells. Biseokeaniamide A did not inhibit IκBα degradation but inhibited IκBα expression. Thus, biseokeaniamide A, a naturally occurring lipopeptide, was identified as a selective inhibitor of LPS signal transduction.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biseokeaniamide A; Lipopolysaccharide; Marine cyanobacterium; Nitric oxide; RAW264.7

Mesh:

Substances:

Year:  2020        PMID: 32173199     DOI: 10.1016/j.bmcl.2020.127069

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Inhibition of Lipopolysaccharide-Induced Inflammatory Signaling by Soft Coral-Derived Prostaglandin A2 in RAW264.7 Cells.

Authors:  Osamu Ohno; Eika Mizuno; Junichiro Miyamoto; Tomoyuki Hoshina; Takuya Sano; Kenji Matsuno
Journal:  Mar Drugs       Date:  2022-05-09       Impact factor: 6.085

Review 2.  Marine Cyanobacteria: A Source of Lead Compounds and their Clinically-Relevant Molecular Targets.

Authors:  Lik Tong Tan; Ma Yadanar Phyo
Journal:  Molecules       Date:  2020-05-08       Impact factor: 4.411

3.  Treatment repurposing for inflammatory bowel disease using literature-related discovery and innovation.

Authors:  Ronald Neil Kostoff; Michael Brandon Briggs; Darla Roye Shores
Journal:  World J Gastroenterol       Date:  2020-09-07       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.